| ［1］Fox W, Sutherland I, Daniels M. A five-year assessment of patients in a controlled trial of streptomycin in pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council. Q J Med, 1954,23(91):347-366. ［2］Mitchison D, Davies G. The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis,2012,16(6):724-732.［3］World Health Orgnization. Treatment for tuberculosis. Guidelines for National Programmes. WHO/TB/97.220. Geneva: World Health Orgnization,1998. ［4］World Health Orgnization. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 Global report on surveillance and response.WHO/HTM/TB/2010.3.Geneva:World Health Organization, 2010.［5］Nuermberger EL, Spigelman MK, Yew WW.Current development and future prospects in chemotherapy of tuberculosis. Respirology, 2010, 15（5）:764-778. ［6］吴小林.治疗结核病新药和药物作用靶位. 国外医药(抗生素分册),2007,28(2):70-73.［7］冯连顺,吕凯, 刘明亮. 结核病的潜在治疗策略. 国外医药(抗生素分册),2010, 31(3):123-132.［8］Rosenthal IM, Zhang M, Williams KN，et al. Daily dosing of rifapentine cures tuberculosis in three months or less in murine model. PLoS Med, 2007,4（12）:e344.［9］Zhang Y. Advances in the treatment of tuberculosis. Clin Pharmacol Ther,2007,82(5):595-600. |
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
